Literature DB >> 18449887

Body size and risk of epithelial ovarian and related cancers: a population-based case-control study.

Catherine M Olsen1,2, Christina M Nagle1, David C Whiteman1, David M Purdie1, Adèle C Green1, Penelope M Webb1.   

Abstract

Different subtypes of ovarian cancer appear to have different causes; however, the association between body mass index (BMI) and the different subtypes is unclear. We examined the associations between body-mass index (BMI) and weight gain and risk of the different histological subtypes of epithelial ovarian cancer in a case-control study in Australia. Cases aged 18-79 with a new diagnosis of invasive epithelial ovarian cancer (n = 1,269) or borderline tumor (n = 311) were identified through a network of clinics and cancer registries throughout Australia. Controls (n = 1,509) were selected from the Electoral Roll. Height and weight (1 year previously, at age 20 and maximum weight) and other risk factor information were ascertained via a self-administered questionnaire. Obesity was positively associated with clear cell tumors (Odds Ratio 2.3; 95% confidence interval 1.2-4.2) but not invasive endometrioid or mucinous tumors. Although there was no association with invasive serous tumors overall (0.9; 0.7-1.2), we did see an increased risk of serous peritoneal tumors (2.9; 1.7-4.9), but not of serous tumors of the ovary and fallopian tube. Of the borderline subtypes, obesity was positively associated with serous (1.8; 1.1-2.8) but not mucinous tumors (1.1; 0.7-1.7). Overweight was not associated with any subtype overall. There was no association with BMI at age 20, or weight gain for any of the histological subtypes. These results add to the current evidence that obesity increases a woman's risk of developing distinct histological subtypes of ovarian cancer. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18449887     DOI: 10.1002/ijc.23509

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.

Authors:  Kazuaki Takahashi; Masataka Takenaka; Ayako Kawabata; Nozomu Yanaihara; Aikou Okamoto
Journal:  Int J Clin Oncol       Date:  2020-01-27       Impact factor: 3.402

2.  Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.

Authors:  Konstantinos I Votanopoulos; Douglas S Swords; Katrina R Swett; Reese W Randle; Perry Shen; John H Stewart; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2013-06-26       Impact factor: 5.344

3.  Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Authors:  Jimmy K Stauffer; Anthony J Scarzello; Jesper B Andersen; Rachel L De Kluyver; Timothy C Back; Jonathan M Weiss; Snorri S Thorgeirsson; Robert H Wiltrout
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

Review 4.  Metabolic syndrome and cancer.

Authors:  Pooja Pothiwala; Sushil K Jain; Subhashini Yaturu
Journal:  Metab Syndr Relat Disord       Date:  2009-08       Impact factor: 1.894

5.  Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer.

Authors:  Ann K Folkins; Aasia Saleemuddin; Leslie A Garrett; Judy E Garber; Michael G Muto; Shelley S Tworoger; Christopher P Crum
Journal:  Gynecol Oncol       Date:  2009-07-16       Impact factor: 5.482

6.  Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study.

Authors:  Joanne Kotsopoulos; Heather J Baer; Shelley S Tworoger
Journal:  Obesity (Silver Spring)       Date:  2009-12-24       Impact factor: 5.002

Review 7.  Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies.

Authors:  V Beral; K Gaitskell; C Hermon; K Moser; G Reeves; R Peto
Journal:  Lancet Oncol       Date:  2012-08-03       Impact factor: 41.316

8.  Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.

Authors: 
Journal:  PLoS Med       Date:  2012-04-03       Impact factor: 11.069

9.  Serum CA125 concentration has inverse correlation with metabolic syndrome.

Authors:  Nam-Seok Joo; Kyu-Nam Kim; Kyung Soo Kim
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

10.  Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.

Authors:  Shelley S Tworoger; Leo J Schouten; Renée T Fortner; Megan S Rice; Synnove F Knutsen; Michael J Orlich; Kala Visvanathan; Alpa V Patel; Mia M Gaudet; Anne Tjønneland; Marina Kvaskoff; Rudolf Kaaks; Antonia Trichopolou; Valeria Pala; N Charlotte Onland-Moret; Inger T Gram; Pilar Amiano; Annika Idahl; Naomi E Allen; Elisabete Weiderpass; Jenny N Poynter; Kim Robien; Graham G Giles; Roger L Milne; Veronica W Setiawan; Melissa A Merritt; Piet A van den Brandt; Anne Zeleniuch-Jacquotte; Alan A Arslan; Katie M O'Brien; Dale P Sandler; Alicja Wolk; Niclas Håkansson; Holly R Harris; Britton Trabert; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.